Comments on: Patent Office Gives Thumbs Up to Genentech’s Cabilly Patent http://www.patentbaristas.com/archives/2009/02/25/patent-office-gives-thumbs-up-to-genentechs-cabilly-patent/?utm_source=rss&utm_medium=rss&utm_campaign=patent-office-gives-thumbs-up-to-genentechs-cabilly-patent Freshly Brewed Bio/Pharma Chat. Served Up Daily. Tue, 07 Sep 2010 07:07:23 -0400 hourly 1 http://wordpress.org/?v=3.0.1 By: Antibody Industry Week in Review | 2.27.09 — The Antibody Blog http://www.patentbaristas.com/archives/2009/02/25/patent-office-gives-thumbs-up-to-genentechs-cabilly-patent/comment-page-1/#comment-65804 Antibody Industry Week in Review | 2.27.09 — The Antibody Blog Fri, 27 Feb 2009 11:25:08 +0000 http://www.patentbaristas.com/archives/2009/02/25/patent-office-gives-thumbs-up-to-genentechs-cabilly-patent/#comment-65804 [...] The USPTO upheld the validity of Genentech’s Cabilly patent.  We covered the development here, and Patent Baristas has covered it here. [...] [...] The USPTO upheld the validity of Genentech’s Cabilly patent.  We covered the development here, and Patent Baristas has covered it here. [...]

]]> By: Simon Elliott http://www.patentbaristas.com/archives/2009/02/25/patent-office-gives-thumbs-up-to-genentechs-cabilly-patent/comment-page-1/#comment-65791 Simon Elliott Thu, 26 Feb 2009 17:19:55 +0000 http://www.patentbaristas.com/archives/2009/02/25/patent-office-gives-thumbs-up-to-genentechs-cabilly-patent/#comment-65791 Enablement, written description, and inequitable conduct, have been raised against Cabilly II. None of these issues are topics of reexamination (in general), and the specific reexamination addressed only issues of obvious-type double patenting. Enablement, written description, and inequitable conduct, have been raised against Cabilly II.

None of these issues are topics of reexamination (in general), and the specific reexamination addressed only issues of obvious-type double patenting.

]]>